Cochrane · systematic review · CD008000
Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
Wang, H, Song, H, Yue, J, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Rheum officinale versus no treatment for chronic kidney disease
Population: Patients with chronic kidney disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Incidence of ESKD Analysis method, calculated by regression analysis: 1/SCr versus time. Rheum officinale vs no treatment | RR 0.53 [0.28, 1] | 2 studies · 124 participants | Low |
Rheum officinale versus captopril for chronic kidney disease
Population: Patients chronic kidney disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Full time working capacity Unclear quality of life scale Rheum officinale vs captopril | RR 1.02 [0.39, 2.71] | 1 study · 20 participants | Low Downgraded: risk of bias |
Part‐time working capacity Unclear quality of life scale Rheum officinale vs captopril | RR 1.64 [0.38, 6.98] | 1 study · 20 participants | Low Downgraded: risk of bias |